Aprea Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aprea Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q2 2024.
  • Aprea Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 758 %, a 6.18% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 758 -50 -6.18% Jun 30, 2024
Q1 2024 710 -1.89 -0.27% Mar 31, 2024
Q4 2023 650 -63 -8.83% Dec 31, 2023
Q3 2023 749 +47 +6.7% Sep 30, 2023
Q2 2023 808 +128 +18.8% Jun 30, 2023
Q1 2023 712 -0.81 -0.11% Mar 31, 2023
Q4 2022 713 +5.71 +0.81% Dec 31, 2022
Q3 2022 702 +39.6 +5.97% Sep 30, 2022
Q2 2022 680 -0.87 -0.13% Jun 30, 2022
Q1 2022 713 +1.91 +0.27% Mar 31, 2022
Q4 2021 708 -79.9 -10.1% Dec 31, 2021
Q3 2021 663 -310 -31.9% Sep 30, 2021
Q2 2021 681 -278 -29% Jun 30, 2021
Q1 2021 711 Mar 31, 2021
Q4 2020 788 Dec 31, 2020
Q3 2020 972 Sep 30, 2020
Q2 2020 959 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.